The seventh annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes the first 9 years of patient enrollment. The Registry includes >15,000 patients from 158 participating hospitals. Trends in device strategy, patient profile at implant and survival are presented. Risk factors for mortality with continuous-flow pumps are updated, and the major causes/modes of death are presented. The adverse event burden is compared between eras, and health-related quality of life is reviewed. A detailed analysis of outcomes after mechanical circulatory support for ambulatory heart failure is presented. Recent summary data from PediMACS and MedaMACS is included. With the current continuous-flow devices, survival at 1 and 2 years is 80
作者：James K, Kirklin；David C, Naftel；Francis D, Pagani；Robert L, Kormos；Lynne W, Stevenson；Elizabeth D, Blume；Susan L, Myers；Marissa A, Miller；J Timothy, Baldwin；James B, Young
来源：The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2015 年 34卷 12期
